ID   Muraoka
AC   CVCL_E042
SY   MURAOKA
DR   Cosmic; 1085912
DR   Wikidata; Q54907089
RX   PubMed=1357816;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=1357816).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 4 fusion (Ex10/Ex5) (PubMed=9738976).
CC   Anecdotal: Cell line name corresponds to the name of the patient.
CC   Derived from site: In situ; Right temporofacial region, hypodermis; UBERON=UBERON_8480069+UBERON_0002072.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=1357816; DOI=10.1007/BF02899678;
RA   Fukushige T., Nagoshi M., Hachitanda Y., Ueno T., Zaizen Y., Suita S.,
RA   Tsuneyoshi M., Kaneko Y., Nakagawara A.;
RT   "Establishment and characterization of a cell line of congenital
RT   primitive neuroectodermal tumor of soft tissue.";
RL   Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol. 62:159-166(1992).
//
RX   PubMed=9738976; DOI=10.1111/j.1349-7006.1998.tb03274.x; PMCID=PMC5921883;
RA   Urano F., Umezawa A., Yabe H., Hong W., Yoshida K., Fujinaga K.,
RA   Hata J.-i.;
RT   "Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF,
RT   available for diagnosis.";
RL   Jpn. J. Cancer Res. 89:703-711(1998).
//